Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Investor Relations
Contact
Community

PRESS RELEASES

Webcast

TRACON Pharmaceuticals at H.C. Wainwright Global Life Sciences Conference

03/09/21 7:00 AM EST

Keyword Search

Year:

05/06/20

Summary Toggle TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020
Printer Friendly

PDF Version
04/24/20

Summary Toggle TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 Trial
Printer Friendly

PDF Version
04/14/20

Summary Toggle TRACON Pharmaceuticals Announces Appointment of Biotechnology Industry Veteran Shahe Garabedian as Senior Vice President of Quality Assurance and Granting of Inducement Award
Printer Friendly

PDF Version
04/06/20

Summary Toggle TRACON Announces May 8 Date for Type B Teleconference Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma
Printer Friendly

PDF Version
03/19/20

Summary Toggle TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors
Printer Friendly

PDF Version
03/16/20

Summary Toggle TRACON Announces Submission of Request for Type B Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma
Printer Friendly

PDF Version
03/09/20

Summary Toggle Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration
Printer Friendly

PDF Version
02/27/20

Summary Toggle TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Printer Friendly

PDF Version
02/20/20

Summary Toggle TRACON to Report Fourth Quarter and Full Year 2019 Financial Results and Company Highlights on February 27, 2020
Printer Friendly

PDF Version
02/07/20

Summary Toggle TRACON Pharmaceuticals Announces Change to Nasdaq Capital Market
Printer Friendly

PDF Version

Pagination

First page
Previous page
…
Page 3
Current page 4
Page 5
Page 6
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Investor Relations

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2021